Home / Recalls / Apollo Care / D-0487-2023

D-0487-2023 Class II Ongoing

Recalled by Apollo Care — Columbia, MO

Recall Details

Product Type
Drugs
Report Date
April 5, 2023
Initiation Date
February 8, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
215 bags

Product Description

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Reason for Recall

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

Distribution Pattern

MO

Code Information

Lot #: AC-016581

Other recalls by Apollo Care

  • D-0409-2025 Class II — FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% (April 15, 2025)
  • D-0640-2023 Class II — VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apoll (May 2, 2023)
  • D-0636-2023 Class II — VANComycin 1.5g added to 500 mL of 0.9% Sodium Chloride Injection, Rx only, Apol (May 2, 2023)
  • D-0642-2023 Class II — VANComycin 2g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only. Apoll (May 2, 2023)
  • D-0633-2023 Class II — Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx (May 2, 2023)
  • D-0635-2023 Class II — Ketamine Injection, 50 mg per 5 mL (10 mg/mL), Single-Use Syringe, Rx only, Apol (May 2, 2023)
  • D-0646-2023 Class II — FentaNYL 500 mcg (2mcg/mL) and Ropivacaine HCL 250 mg (0.1%) added to 250 mL 0.9 (May 2, 2023)
  • D-0639-2023 Class II — VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)
  • D-0634-2023 Class II — FentaNYL 50 mcg/mL (2,500mcg Total Dose), 50 mL Syringe, Rx Only, Apollo Care, L (May 2, 2023)
  • D-0647-2023 Class II — VANComycin 1.5g added to 250 mL of 0.9% Sodium Chloride Injection, Rx only, Apol (May 2, 2023)